But the question, "why only vaccinate girls?" continued to linger. Recently CNBC announced that Merck decided to seek FDA approval for use in boys, as well. FDA approval could be a great step in reducing HPV disease and transmission of genital warts - though it is definitely only one tool to protect against STDs.
Unfortunately, Gardasil is extremely costly, $360-$375 for the entire series. Not all insurance covers this vaccine. Additionally, it requires 3 shots, multiple doctor visits. Without a regular source of care, it could be difficult to ensure that teens get the entire vaccination series. Additionally, this vaccine does not protect against the most common sexually transmitted diseases: chlamydia, gonorrhea, and herpes. Thus, wise discretion of sexual partners, regular STD screenings, and consistent use of condoms are important for anyone engaging in sexual activity.
This is an interesting development worth keeping an eye on.